Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T17:57:02.159Z.
Calculation as of: 2026-10-06T17:57:02.159Z.
Quote observation: 2026-10-06T17:53:40.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 49c5230cca2432c6fd0637270100fe2f3d02ebc9238e4fdbb1f4ddcca099658b
PEG RATIO
N/A
iSpecimen Inc.
Market Cap
$2.77M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| iSpecimen Inc. (ISPC) | $2.77M | N/A |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.84M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.01M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $3.05M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.47M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.11M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
